<SEC-DOCUMENT>0001213900-24-070285-index.html : 20240816
<SEC-HEADER>0001213900-24-070285.hdr.sgml : 20240816
<ACCEPTANCE-DATETIME>20240816163555
ACCESSION NUMBER:		0001213900-24-070285
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		19
CONFORMED PERIOD OF REPORT:	20240812
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240816
DATE AS OF CHANGE:		20240816

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Citius Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001506251
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				273425913
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38174
		FILM NUMBER:		241217188

	BUSINESS ADDRESS:	
		STREET 1:		11 COMMERCE DRIVE
		STREET 2:		1ST FLOOR
		CITY:			CRANFORD
		STATE:			NJ
		ZIP:			07016
		BUSINESS PHONE:		(908) 967-6676

	MAIL ADDRESS:	
		STREET 1:		11 COMMERCE DRIVE
		STREET 2:		1ST FLOOR
		CITY:			CRANFORD
		STATE:			NJ
		ZIP:			07016

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Trail One, Inc.
		DATE OF NAME CHANGE:	20110314

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TrailOne, Inc.
		DATE OF NAME CHANGE:	20101119
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ea0211482-8k_citius.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
Document 1 - file: ea0211482-8k_citius.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ea021148201ex10-1_citius.htm
<DESCRIPTION>AMENDED AND RESTATED SHARED SERVICES AGREEMENT, DATED AUGUST 12, 2024, BETWEEN CITIUS PHARMACEUTICALS, INC
<TEXT>
Document 2 - file: ea021148201ex10-1_citius.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>ea021148201ex10-2_citius.htm
<DESCRIPTION>AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT, DATED AS OF AUGUST 12, 2024 BY AND BETWEEN CITIUS ONCOLOGY, INC. AND THE SIGNATORIES THERETO
<TEXT>
Document 3 - file: ea021148201ex10-2_citius.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>4
<FILENAME>ea021148201ex10-3_citius.htm
<DESCRIPTION>SIDE LETTER AGREEMENT, DATED AUGUST 12, 2024, BY AND BY AND AMONG CITIUS PHARMACEUTICALS, INC., CITIUS ONCOLOGY, INC., TENX KEANE ACQUISITION AND TENX MERGER SUB, INC
<TEXT>
Document 4 - file: ea021148201ex10-3_citius.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>5
<FILENAME>ea021148201ex10-4_citius.htm
<DESCRIPTION>PROMISSORY NOTE, DATED AUGUST 16, 2024, ISSUED TO CITIUS PHARMACEUTICALS, INC. BY CITIUS ONCOLOGY, INC.
<TEXT>
Document 5 - file: ea021148201ex10-4_citius.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>6
<FILENAME>ea021148201ex99-1_citius.htm
<DESCRIPTION>PRESS RELEASE DATED AUGUST 12, 2024
<TEXT>
Document 6 - file: ea021148201ex99-1_citius.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>ex99-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 7 - file: ex99-1_001.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>ctxr-20240812.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
Document 8 - file: ctxr-20240812.xsd

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>ctxr-20240812_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
Document 9 - file: ctxr-20240812_lab.xml

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>ctxr-20240812_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
Document 10 - file: ctxr-20240812_pre.xml

</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
Document 12 - file: R1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>13
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
Document 13 - file: Financial_Report.xlsx

</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
Document 14 - file: Show.js

</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
Document 15 - file: report.css

</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
Document 17 - file: FilingSummary.html

Document 17 - RAW XML: FilingSummary.xml

</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>19
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
Document 19 - file: MetaLinks.json

</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>20
<FILENAME>0001213900-24-070285-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
Document 20 - file: 0001213900-24-070285-xbrl.zip

</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>ea0211482-8k_citius_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
Document 21 - file: ea0211482-8k_citius_htm.html

Document 21 - RAW XML: ea0211482-8k_citius_htm.xml

</DOCUMENT>
</SEC-DOCUMENT>